Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy - Concepedia

Concepedia

Publication | Open Access

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

DOI Full Paper Access

365

Citations

51

References

2014

Year

Suzanne Leijen, Sjaak A. Burgers, Paul Baas, Dick Pluim, Matthijs M. Tibben, Erik van Werkhoven, Enzo Alessio, Gianni Sava, Jos H. Beijnen, Jan H.M. Schellens

Investigational New Drugs

OncologyPhase I/ii StudyMedicineBronchial NeoplasmPharmacotherapyAnti-cancer AgentCancer TreatmentRuthenium Compound Nami-aPharmacologyTumor MicroenvironmentLung CancerCancer ResearchFirst Line Therapy

References

	Year	Citations

Page 1

Page 1